Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Purpose is to compare the frequency of events (presence of Disseminated Tumour Cells,
clinical recurrence and/or death) after 1 and 2 years of adjuvant treatment with anastrozole
and fulvestrant or anastrozole alone in patients with early breast cancer.